–rarity of completed suicide as an outcome
–difficulty in identifying individuals with outcome of completed suicide
–difficulty of classifying outcomes of non-fatal suicidal behavior
–difficulty obtaining data on drug exposure
–lack of suitable control/comparison groups
–confounding by
indication
–privacy restrictions